Related Experiment Video

Updated: May 11, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells

Thippeswamy Gulappa1, Ramadevi Subramani Reddy, Suman Suman

  • 1Department of Biomedical Sciences, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA.

Cancer Letters
|May 21, 2013
PubMed

Insights

3,9-dihydroxy-2-prenylcoumestan (pso) inhibits castration-resistant prostate cancer (CRPC) cell growth by causing G0/G1 cell cycle arrest. This effect is mediated by regulating cyclin-dependent kinase inhibitors and downregulating cdk4.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Castration-resistant prostate cancer (CRPC) remains a significant therapeutic challenge.
  • Novel therapeutic agents targeting CRPC cell proliferation are urgently needed.

Purpose of the Study:

  • To investigate the anti-cancer effects of 3,9-dihydroxy-2-prenylcoumestan (pso), a furanocoumarin, on CRPC cell lines.
  • To elucidate the molecular mechanisms underlying pso's inhibitory effects on CRPC cell growth.

Main Methods:

  • Treatment of PC-3 and C4-2B CRPC cell lines with pso.
  • Cell cycle analysis to assess cell cycle distribution.
  • Quantitative analysis of gene and protein expression for cyclins, cyclin-dependent kinases (cdks), and cdk inhibitors.

Main Results:

  • Pso significantly induced G0/G1 cell cycle arrest and inhibited cell growth in CRPC cell lines.
  • Molecular analysis revealed transcriptional regulation of p21 and p27, and significant downregulation of cdk4.
  • Overexpression of cdk4 or silencing of p21/p27 rescued the pso-induced G0/G1 arrest.

Conclusions:

  • Pso exhibits potent anti-proliferative activity against CRPC cells.
  • G0/G1 cell cycle arrest, modulated by cdk inhibitors and cdk4, is a key mechanism of pso's action.
  • Pso represents a potential therapeutic candidate for CRPC treatment.
Keywords:
Castration-resistant prostate cancerCell cycle arrestCyclin-dependent kinaseCyclinsGrowth inhibition

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...